ESLA earnings: next report 2026-09-02, real EPS beat/miss history, analyst consensus Buy, P/E -2.20. Updated 2026-07-23.
Estrella Immunopharma (ESLA) Research Hub
Estrella Immunopharma (ESLA) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-09-11, shares last closed at 0.6596 USD (+3.39%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -2.20, market cap 0.03B. This hub links to the full technical, earnings and options research available for ESLA.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 0.6596 USD (+3.39%) |
| 52-week range | 0.585 USD – 1.11 USD |
| Trend regime | Range |
| 14-day RSI | 36.1 (Bearish) |
| Trailing P/E | -2.20 |
| Market cap | 0.03B |
| Dividend yield | 0.00% |
| Next earnings | 2026-09-02 |
Available research for ESLA
Covered Call on ESLA: how it works, illustrative setup around the real 0.6596 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on ESLA: how it works, illustrative setup around the real 0.6596 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on ESLA: how it works, illustrative setup around the real 0.6596 USD price, max profit/loss, breakeven and when to use it. Educational.
ESLA technical analysis: range, last 0.6596 USD, RSI 36.1, 52w range 0.585 USD–1.11 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is ESLA in?
Estrella Immunopharma (ESLA) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is ESLA in an uptrend or downtrend?
As of 2026-09-11, ESLA is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is ESLA's trailing P/E ratio?
ESLA's trailing P/E is -2.20, with a market cap of 0.03B. See the earnings research page for full valuation detail.
When does ESLA next report earnings?
ESLA is next scheduled to report earnings on 2026-09-02, with a consensus EPS estimate of -0.09 USD.